Geriatric Medicine is the branch of medication concerned about all elements of wellbeing and sickness in matured populace. It is the biggest medicinal forte. The division thoroughly considers medicinal, clinical, social and preventive measures of wiped out wellbeing ordinarily among population over 65 years. The larger parts of more aged grown-ups are not able to take their prescription unequivocally on given time because of complicated physiological and medicinal issues. To have quick recovery of sicknesses or disease the geriatric populace needs unique consideration and care.
Based on the Geriatric Medicine market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Geriatric Medicine market covered in Chapter 5:
AstraZeneca plc
GlaxoSmithKline plc
Eli Lilly and Company
Sanofi S.A.
Pfizer, Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Abbott Laboratories, Inc.
Novartis International AG
Merck & Company Inc.
In Chapter 6, on the basis of types, the Geriatric Medicine market from 2015 to 2025 is primarily split into:
Anticoagulant
Proton-pump inhibitors (PPIs)
Antidiabetic
Statins
Antihypertensive
Analgesic
Antipsychotic
Others
In Chapter 7, on the basis of applications, the Geriatric Medicine market from 2015 to 2025 covers:
Respiratory
Osteoporosis
Neurological
Cancer
Arthritis
Cardiovascular
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Geriatric Medicine. Industry analysis & Market Report on Geriatric Medicine is a syndicated market report, published as Global Geriatric Medicine Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Geriatric Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.